{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T02:00:16Z","timestamp":1769824816203,"version":"3.49.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T00:00:00Z","timestamp":1642377600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T00:00:00Z","timestamp":1642377600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Jilin Province Youth Scientific and Technological Talent Support Project","award":["QT202111"],"award-info":[{"award-number":["QT202111"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s00432-021-03899-7","type":"journal-article","created":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T14:05:08Z","timestamp":1642428308000},"page":"1073-1085","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["In vivo and in vitro inhibition of SCLC by combining dual cancer-specific recombinant adenovirus with Etoposide"],"prefix":"10.1007","volume":"148","author":[{"given":"Tingyu","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinbo","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jihao","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6795-6088","authenticated-orcid":false,"given":"Yiquan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yilong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanzhi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiru","family":"Xiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaru","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ningyi","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangzhe","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,17]]},"reference":[{"key":"3899_CR1","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/S1470-2045(16)30098-5","volume":"17","author":"SJ Antonia","year":"2016","unstructured":"Antonia SJ, Lopez-Martin JA, Bendell J, Ott PA, Taylor M, Eder JP, Jager D, Pietanza MC, Le DT, de Braud F, Morse MA, Ascierto PA, Horn L, Amin A, Pillai RN, Evans J, Chau I, Bono P, Atmaca A, Sharma P, Harbison CT, Lin CS, Christensen O, Calvo E (2016) Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1\/2 trial. Lancet Oncol 17:883\u2013895","journal-title":"Lancet Oncol"},{"issue":"2020","key":"3899_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ccm.2019.10.001","volume":"41","author":"BC Bade","year":"2020","unstructured":"Bade BC, Dela Cruz CS, Cancer L (2020) Epidemiology, etiology, and prevention. Clin Chest Med 41(2020):1\u201324","journal-title":"Clin Chest Med"},{"key":"3899_CR3","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nrc2628","volume":"9","author":"F Balkwill","year":"2009","unstructured":"Balkwill F (2009) Tumour necrosis factor and cancer. Nat Rev Cancer 9:361\u2013371","journal-title":"Nat Rev Cancer"},{"issue":"2018","key":"3899_CR4","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A, Global Cancer Statistics (2018) GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(2018):394\u2013424","journal-title":"CA Cancer J Clin"},{"key":"3899_CR5","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/cncr.29098","volume":"121","author":"LA Byers","year":"2015","unstructured":"Byers LA, Rudin CM (2015) Small cell lung cancer: where do we go from here? Cancer 121:664\u2013672","journal-title":"Cancer"},{"key":"3899_CR6","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1158\/2326-6066.CIR-14-0015","volume":"2","author":"EA Chiocca","year":"2014","unstructured":"Chiocca EA, Rabkin SD (2014) Oncolytic viruses and their application to cancer immunotherapy. Cancer Immunol Res 2:295\u2013300","journal-title":"Cancer Immunol Res"},{"key":"3899_CR7","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.ymthe.2004.07.021","volume":"10","author":"E Chiocca","year":"2004","unstructured":"Chiocca E, Abbed K, Tatter S, Louis D, Hochberg F, Barker F, Kracher J, Grossman S, Fisher J, Carson K, Rosenblum M, Mikkelsen T, Olson J, Markert J, Rosenfeld S, Nabors L, Brem S, Phuphanich S, Freeman S, Kaplan R, Zwiebel J (2004) A phase I open-label, dose-escalation, multi-institutional trial of injection with an E1B-attenuated adenovirus, ONYX-015, into the peritumoral region of recurrent malignant gliomas, in the adjuvant setting. Mol Ther J Am Soc Gene Ther 10:958\u2013966","journal-title":"Mol Ther J Am Soc Gene Ther"},{"key":"3899_CR8","doi-asserted-by":"publisher","first-page":"27729","DOI":"10.1074\/jbc.M303114200","volume":"278","author":"AAAM Danen-Van Oorschot","year":"2003","unstructured":"Danen-Van Oorschot AAAM, Zhang YH, Leliveld SR, Rohn JL, Seelen MCMJ, Bolk MW, Van Zon A, Erkeland SJ, Abrahams JP, Mumberg D, Noteborn MHM (2003) Importance of nuclear localization of apoptin for tumor-specific induction of apoptosis. J Biol Chem 278:27729\u201327736","journal-title":"J Biol Chem"},{"issue":"Suppl 6","key":"3899_CR9","doi-asserted-by":"publisher","first-page":"vi99","DOI":"10.1093\/annonc\/mdt178","volume":"24","author":"M Fruh","year":"2013","unstructured":"Fruh M, De Ruysscher D, Popat S, Crino L, Peters S, Felip E, E.G.W. Group (2013) Small-cell lung cancer (SCLC): ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 24(Suppl 6):vi99\u2013vi105","journal-title":"Ann Oncol"},{"key":"3899_CR10","doi-asserted-by":"publisher","first-page":"e346","DOI":"10.2741\/976","volume":"8","author":"G Fulci","year":"2003","unstructured":"Fulci G, Chiocca E (2003) Oncolytic viruses for the therapy of brain tumors and other solid malignancies: a review. Front Biosci 8:e346-360","journal-title":"Front Biosci"},{"key":"3899_CR11","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1056\/NEJMsa0802902","volume":"360","author":"D Gu","year":"2009","unstructured":"Gu D, Kelly TN, Wu X, Chen J, Samet JM, Huang JF, Zhu M, Chen JC, Chen CS, Duan X, Klag MJ, He J (2009) Mortality attributable to smoking in China. N Engl J Med 360:150\u2013159","journal-title":"N Engl J Med"},{"key":"3899_CR12","doi-asserted-by":"publisher","first-page":"7535","DOI":"10.1128\/JVI.02741-05","volume":"80","author":"DW Heilman","year":"2006","unstructured":"Heilman DW, Teodoro JG, Green MR (2006) Apoptin nucleocytoplasmic shuttling is required for cell type-specific localization, apoptosis, and recruitment of the anaphase-promoting complex\/cyclosome to PML bodies. J Virol 80:7535\u20137545","journal-title":"J Virol"},{"key":"3899_CR13","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1089\/hum.2014.069","volume":"26","author":"M Hirvinen","year":"2015","unstructured":"Hirvinen M, Rajecki M, Kapanen M, Parviainen S, Rouvinen-Lagerstr\u00f6m N, Diaconu I, Nokisalmi P, Tenhunen M, Hemminki A, Cerullo V (2015) Immunological effects of a tumor necrosis factor alpha-armed oncolytic adenovirus. Hum Gene Ther 26:134\u2013144","journal-title":"Hum Gene Ther"},{"key":"3899_CR14","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1089\/hum.2006.17.1214","volume":"17","author":"N Kemeny","year":"2006","unstructured":"Kemeny N, Brown K, Covey A, Kim T, Bhargava A, Brody L, Guilfoyle B, Haag N, Karrasch M, Glasschroeder B, Knoll A, Getrajdman G, Kowal K, Jarnagin W, Fong Y (2006) Phase I, open-label, dose-escalating study of a genetically engineered herpes simplex virus, NV1020, in subjects with metastatic colorectal carcinoma to the liver. Hum Gene Ther 17:1214\u20131224","journal-title":"Hum Gene Ther"},{"key":"3899_CR15","doi-asserted-by":"publisher","first-page":"747","DOI":"10.3892\/ijmm.2012.1077","volume":"30","author":"L Liu","year":"2012","unstructured":"Liu L, Wu W, Zhu G, Liu L, Guan G, Li X, Jin N, Chi B (2012) Therapeutic efficacy of an hTERT promoter-driven oncolytic adenovirus that expresses apoptin in gastric carcinoma. Int J Mol Med 30:747\u2013754","journal-title":"Int J Mol Med"},{"key":"3899_CR16","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1245\/ASO.2005.06.004","volume":"12","author":"KK Ng","year":"2005","unstructured":"Ng KK, Vauthey JN, Pawlik TM, Lauwers GY, Regimbeau JM, Belghiti J, Ikai I, Yamaoka Y, Curley SA, Nagorney DM, Ng IO, Fan ST, Poon RT, C. International Cooperative Study Group on Hepatocellular (2005) Is hepatic resection for large or multinodular hepatocellular carcinoma justified? Results from a multi-institutional database. Ann Surg Oncol 12:364\u2013373","journal-title":"Ann Surg Oncol"},{"key":"3899_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1080\/03079459508419046","volume":"24","author":"MH Noteborn","year":"1995","unstructured":"Noteborn MH, Koch G (1995) Chicken anaemia virus infection: molecular basis of pathogenicity. Avian Pathol J WVPA 24:11\u201331","journal-title":"Avian Pathol J WVPA"},{"key":"3899_CR18","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.1128\/jvi.65.6.3131-3139.1991","volume":"65","author":"MHM Noteborn","year":"1991","unstructured":"Noteborn MHM, De Boer GF, Van Roozelaar DJ, Karreman C, Kranenburg O, Vos JG, Jeurissen SHM, Hoeben RC, Zantema A, Koch G, Van Ormondt H, Van Der Eb AJ (1991) Characterization of cloned chicken anemia virus DNA that contains all elements for the infectious replication cycle. J Virol 65:3131\u20133139","journal-title":"J Virol"},{"key":"3899_CR19","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1128\/jvi.68.1.346-351.1994","volume":"68","author":"MH Noteborn","year":"1994","unstructured":"Noteborn MH, Todd D, Verschueren CA, deGauw HW, Curran WL, Veldkamp S, Douglas AJ, McNulty MS, van der EA, Koch G (1994) A single chicken anemia virus protein induces apoptosis. J Virol 68:346\u2013351","journal-title":"J Virol"},{"issue":"Pt 4","key":"3899_CR20","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1099\/0022-1317-75-4-905","volume":"75","author":"KV Phenix","year":"1994","unstructured":"Phenix KV, Meehan BM, Todd D, McNulty MS (1994) Transcriptional analysis and genome expression of chicken anaemia virus. J Gen Virol 75(Pt 4):905\u2013909","journal-title":"J Gen Virol"},{"key":"3899_CR21","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.taap.2014.08.008","volume":"280","author":"Y Qi","year":"2014","unstructured":"Qi Y, Guo H, Hu N, He D, Zhang S, Chu Y, Huang Y, Li X, Sun L, Jin N (2014) Preclinical pharmacology and toxicology study of Ad-hTERT-E1a-Apoptin, a novel dual cancer-specific oncolytic adenovirus. Toxicol Appl Pharmacol 280:362\u2013369","journal-title":"Toxicol Appl Pharmacol"},{"key":"3899_CR22","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.cellimm.2014.03.009","volume":"289","author":"Y Qian","year":"2014","unstructured":"Qian Y, Yang L, Cao S (2014) Telomeres and telomerase in T cells of tumor immunity. Cell Immunol 289:63\u201369","journal-title":"Cell Immunol"},{"key":"3899_CR23","first-page":"493","volume":"27","author":"LJ Reed","year":"1938","unstructured":"Reed LJ, Meunch H (1938) A simple method of estimating fifty percent endpoints. Am J Hyg 27:493\u2013497","journal-title":"Am J Hyg"},{"key":"3899_CR24","doi-asserted-by":"publisher","first-page":"50820","DOI":"10.1074\/jbc.M208557200","volume":"277","author":"JL Rohn","year":"2002","unstructured":"Rohn JL, Zhang YH, Aalbers RIJM, Otto N, Den Hertog J, Henriquez NV, Van de Velde CJH, Kuppen PJK, Mumberg D, Donner P, Noteborn MHM (2002) A tumor-specific kinase activity regulates the viral death protein apoptin. J Biol Chem 277:50820\u201350827","journal-title":"J Biol Chem"},{"key":"3899_CR25","doi-asserted-by":"publisher","first-page":"153","DOI":"10.2174\/1568009617666170222123925","volume":"18","author":"M Sato-Dahlman","year":"2018","unstructured":"Sato-Dahlman M, Yamamoto M (2018) The development of oncolytic adenovirus therapy in the past and future\u2014for the case of pancreatic cancer. Curr Cancer Drug Targets 18:153\u2013161","journal-title":"Curr Cancer Drug Targets"},{"key":"3899_CR26","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209\u2013249","journal-title":"CA Cancer J Clin"},{"key":"3899_CR27","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/nrc3397","volume":"12","author":"A Umar","year":"2012","unstructured":"Umar A, Dunn BK, Greenwald P (2012) Future directions in cancer prevention. Nat Rev Cancer 12:835\u2013848","journal-title":"Nat Rev Cancer"},{"key":"3899_CR28","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.3760\/cma.j.issn.0366-6999.2011.21.032","volume":"124","author":"H Wang","year":"2011","unstructured":"Wang H, Satoh M, Chen GP, Li DC, Hamada H, Arai Y (2011) E1A, E1B double-restricted adenovirus enhances the cytotoxicity and antitumor activity of gemcitabine to renal cell carcinoma. Chin Med J 124:1082\u20131087","journal-title":"Chin Med J"},{"key":"3899_CR29","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1476-4598-9-10","volume":"9","author":"L Xiao","year":"2010","unstructured":"Xiao L, Yan L, Zhongmei W, Chang L, Huijun L, Mingyao T, Kuoshi J, Lili S, Pegn G, Encheng Y, Xiaohong X, Shifu K, Zhuoyue W, Yuhang W, Ningyi J (2010) Potent anti-tumor effects of a dual specific oncolytic adenovirus expressing apoptin in vitro and in vivo. Mol Cancer 9:10","journal-title":"Mol Cancer"},{"key":"3899_CR30","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3892\/etm.2014.2086","volume":"9","author":"G Yang","year":"2015","unstructured":"Yang G, Meng X, Sun L, Hu N, Jiang S, Sheng Y, Chen Z, Zhou Y, Chen D, Li X, Jin N (2015) Antitumor effects of a dual cancer-specific oncolytic adenovirus on colorectal cancer in vitro and in vivo. Exp Ther Med 9:327\u2013334","journal-title":"Exp Ther Med"},{"key":"3899_CR31","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/sj.mt.6300023","volume":"15","author":"JY Yoo","year":"2007","unstructured":"Yoo JY, Kim JH, Kwon YG, Kim EC, Kim NK, Choi HJ, Yun CO (2007) VEGF-specific short hairpin RNA-expressing oncolytic adenovirus elicits potent inhibition of angiogenesis and tumor growth. Mol Ther 15:295\u2013302","journal-title":"Mol Ther"},{"key":"3899_CR32","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.3892\/ijo.2013.1783","volume":"42","author":"M Zhang","year":"2013","unstructured":"Zhang M, Wang J, Li C, Hu N, Wang K, Ji H, He D, Quan C, Li X, Jin N, Li Y (2013) Potent growth-inhibitory effect of a dual cancer-specific oncolytic adenovirus expressing apoptin on prostate carcinoma. Int J Oncol 42:1052\u20131060","journal-title":"Int J Oncol"},{"key":"3899_CR33","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.canlet.2015.01.044","volume":"360","author":"D Zhang","year":"2015","unstructured":"Zhang D, Xiao YF, Zhang JW, Xie R, Hu CJ, Tang B, Wang SM, Wu YY, Hao NB, Yang SM (2015) miR-1182 attenuates gastric cancer proliferation and metastasis by targeting the open reading frame of hTERT. Cancer Lett 360:151\u2013159","journal-title":"Cancer Lett"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-021-03899-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-021-03899-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-021-03899-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T13:21:48Z","timestamp":1726492908000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-021-03899-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,17]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["3899"],"URL":"https:\/\/doi.org\/10.1007\/s00432-021-03899-7","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,17]]},"assertion":[{"value":"9 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The animal study was reviewed and approved by the Institutional Animal Care and Use Committee (IACUC) of the Changchun University of Chinese Medicine.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}